To report the 5-year results of the Stanford University Network for Diagnosis of Retinopathy of Prematurity (SUNDROP) telemedicine initiative.
INTRODUCTION
Retinopathy of prematurity (ROP) is a visionthreatening disease of disordered retinal vasculature development in premature and low birth weight infants. 1, 2 The underdeveloped retina overcompensates for ischemia at birth by promoting angiogenesis that can damage nearby structures through retinal edema, traction, or detachment. 3, 4 At United States schools, ROP accounts for 14% of pediatric blindness. 5 The World Health Organization (WHO) found ROP to be the leading cause of avoidable visual impairment in high-income countries and the second leading cause in middle-income countries, 6 accounting for 15% to 35% of pediatric blindness in some nations. [7] [8] [9] Randomized trials and observational studies demonstrate that cryotherapy, 10, 11 laser photocoagulation, [12] [13] [14] [15] and intravitreal bevacizumab 16, 17 can preserve vision when administered early in the course of disease.
14 Armed with vision-saving treatments, public health efforts have shifted toward screening and promptly identifying high-risk infants. The landmark Early Treatment of Retinopathy of Prematurity (ETROP) trial developed standardized screening time lines based on the natural course of ROP and defined the criteria for initiation of treatment (ETROP type 1). 4, 14 In 2013, the American Academy of Pediatrics (AAP) and the American Academy of Ophthalmology (AAO) released updated ROP screening recommendations stating that every infant with birth weight less than or equal to 1,500 g, estimated gestational age 107 less than or equal to 30 weeks, or an unstable clinical course deemed high risk by the attending pediatrician should be screened with serial eye examinations until the infant meets criteria for terminating screening. 18 Although screening and treatment are highly effective at preventing ROP related vision loss, thousands of at-risk infants worldwide remain unscreened because of a shortage of ROP specialists. 19 The number of neonates requiring screening is increasing because sophisticated neonatal intensive care unit (NICU) technology enables the survival of younger infants worldwide. At the same time, the number of physicians willing and able to care for these patients is dwindling. Pediatric ophthalmologists are already at a shortage in the United States, 8 and a survey by the AAO projects a 17% decline in the current ROP workforce due to legal liability, travel burden, poor reimbursement, and significant time commitments. 20 These shortages are amplified in middle-income countries where there are fewer practicing pediatric ophthalmologists. 19 The ROP screening burden may be alleviated with the use of wide-angle digital retinal photography interpreted remotely to complement the work of pediatric ophthalmologists and retina specialists. The ROP screening examination relies upon visual analysis of anatomic structures that can be seen in a photograph.
Retinal image devices such as the RetCam II (Clarity Medical Systems, Pleasanton, CA) are now able to capture high-resolution digital images from patients in one location and transmit them to a remote expert for interpretation. Telemedicine, the use of electronic technology for remote health care, is promising for ROP screening because it may serve as a cost-effective complement to traditional bedside binocular indirect ophthalmoscope (BIO) examination performed by the ophthalmologist. 21 Among studies comparing telemedicine with concurrent BIO for detection of treatment-warranted ROP, all have found high diagnostic accuracy. [22] [23] [24] [25] [26] [27] [28] Most importantly, no infant in any published telemedicine study with disease necessitating intervention has been missed.
The Stanford University Network for the Diagnosis of Retinopathy of Prematurity (SUNDROP) is an active community initiative that uses telemedicine as the sole in-hospital screening technique for high-risk infants born at six satellite NICUs located throughout Northern California. The SUNDROP initiative was developed to reduce blindness and poor visual outcomes from ROP by providing infants in rural and county hospitals with quaternary care. The SUN-DROP initiative is the first true implementation of telemedicine for ROP screening in the United States. All infants meeting AAP/AAO criteria are screened with RetCam II images that are sent to the Stanford University Byers Eye Institute reading center for remote interpretation by an ROP specialist, and outcomes are confirmed with outpatient ophthalmology follow-up. This report summarizes the 5-year results of the SUNDROP initiative.
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PATIENTS AND METHODS

Ethical Considerations
The institutional review board at Stanford University School of Medicine approved this retrospective review of the SUNDROP telemedicine initiative. All research was conducted in compliance with human subjects regulations and adhered to the tenets of the Declaration of Helsinki.
Participants and Baseline Characteristics
All infants at six participating NICUs who met AAP/AAO ROP screening criteria 18 were enrolled in the SUNDROP telemedicine initiative. The six NICUs are located throughout Northern California and include level I, II, and III nurseries encompassing community, private, and county hospitals. Thus, the screened infants are a demographically, ethnically, and socioeconomically diverse population. This study includes infants screened from December 1, 2005 , to November 30, 2010. The birth weight was obtained from the delivery record and further classified into categories of extremely low birth weight (less than 1,000 g), very low birth weight (1,000-1,499 g) and low birth weight (1,500-2,500 g) consistent with WHO classifications. Gender, estimated gestational age, and multiplicity data were also obtained from the delivery records at each hospital. Births were classified as single, twin (including both dizygotic and monozygotic), or triplet.
Photography Protocol
NICU nurses were trained to take wide-angle (130° lens) retinal photographs using the RetCam II as previously described. [29] [30] [31] [32] [33] Retinal images were obtained using published photography protocols with a goal of five or more clearly focused images of each area of the eye, as shown in the Figure (page  111) . 25, [29] [30] [31] [32] [33] In cases of inadequate exposure, artifact, poor visualization of the periphery, or lack of a complete standardized image set, a repeat telemedicine evaluation was performed within 48 hours. In the latter half of the first year, iris images from each eye were included in line with changes in AAP/ AAO guidelines. 34 The nurses closely monitored infant's vital signs, cardiopulmonary status, and oxygen saturations during the examination. If bradycardia, apnea, or other abnormalities developed during retinal imaging, the examination was halted and the NICU staff immediately stabilized the infant. Repeat examinations were postponed for 48 hours. In cases in which repeat retinal photography examination could not be performed, the infant was evaluated with bedside BIO.
Data Collection and Management
All patient retinal photographs and data were transferred via secure and encrypted email or by courier. Families and the NICU staff were informed of the im- age interpretation within 24 hours (most often, later in the same day). Study data were collected and managed using Stanford University's REDCap (Research Electronic Data Capture), a secure, Web-based application designed to support data capture in a HIPAA-compliant fashion for research studies. 35 The research was supported by a Center for Clinical Informatics grant.
Inpatient Telemedicine Screening
All infants underwent inpatient retinal photography for ROP screening with remote image evaluation at the Stanford Byers Eye Institute reading center by a single ROP specialist (DMM). Infants meeting AAP/ AAO criteria were screened solely with retinal photography until discharge from the hospital unless they had an image interpreted as suggesting treatmentwarranted ROP (TW-ROP), defined as ETROP type 1.
14 An interpretation of TW-ROP initiated a mandatory bedside BIO by the ROP specialist within 24 hours. The frequency of screening examinations followed those recommended by the joint criteria statement (eg, weekly screening for a neonate whose images demonstrate zone II, stage 2 ROP without plus disease). 18 All infants were followed up until they met termination criteria delineated by the AAP/AAO: (1) zone III retinal vascularization attained without prior zone I or II ROP, (2) full retinal vascularization, (3) postmenstrual age of 45 weeks, (4) no pre-threshold or worse disease present, or regression of ROP with no abnormal vascular tissue present that is capable of reactivation and progression. 18 Follow-up in high-risk infant clinic allowed complete capture of patient outcomes.
Outcomes
The primary outcomes were TW-ROP and anatomic outcomes (vision loss, retinal detachment, retrolental mass, or macular fold). Images were interpreted using the standardized international classification system criteria 36 by one ROP specialist (DMM). TW-ROP was defined as ETROP type 1 that includes: (1) zone I, any stage ROP with plus disease, (2) zone I, stage 3 ROP with or without plus disease, (3) zone II, stage 2 or 3 ROP with plus disease, (4) any plus disease, or (5) any stage 4 or higher disease.
14 A diagnosis of TW-ROP initiated a subsequent mandatory bedside BIO within 24 hours (usually faster) by the attending ophthalmologist (DMM). Treatment decisions were based exclusively on the bedside BIO examination findings. All patients who required treatment were followed up in outpatient ophthalmology clinic and received serial bedside BIO (they were no longer screened with the SUN-DROP telemedicine protocol). The clinical diagnosis determined with bedside BIO was considered the gold standard reference. All patients received at least one mandatory bedside BIO examination within 1 week of NICU discharge.
Statistical Analysis
All data were analyzed using SAS Enterprise Guide version 5.1 All variables were graphically examined for normal distributions and outliers to determine the appropriate statistical tests. Measures of central tendency and variation were used to describe the study population. All infants who had TW-ROP were compared with the non-ROP cohort with respect to baseline characteristics using t-test and chi-squared analyses as appropriate. Statistical significance level was set as a two-tailed test with α < 0.05. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the detection of TW-ROP in the SUNDROP study during the first 5 years of enrollment. The telemedicine image interpretation was compared to the gold standard BIO results from the outpatient ophthalmology clinic.
RESULTS
Participants
During the 5-year study period, 511 infants (1,022 eyes) were screened for ROP with images interpreted remotely at the Stanford Byers Eye Institute reading center. All 511 infants had complete outcome records with respect to TW-ROP status and adverse anatomical outcomes collected from clinic records. The total number of examinations and images captured was available for 502 infants (98.2%). Details on birth weight and estimated gestational age were available for 424 infants (83.0%). The SUNDROP initiative included 1,783 examinations and 22,215 images; the median number of examinations per infant was 2.0 (mean: 3.55; range: 1 to 20), and the median number of images per patient was 30.0 (mean: 32; range: 6 to 244). The mean birth weight of all patients was 1,255 g (SD: 358 g); mean gestational age was 28 weeks and 6 days (SD: 2.8 weeks); and there were slightly more male than female infants (55% vs 45%). The study included 37 twins (74 infants, 14.5%) and two sets of triplets (six infants, 1.2%).
Treatment-Warranted ROP and Adverse Outcomes
From the 1,783 examinations performed by NICU nurses and reviewed by an ROP specialist (DMM) at the Stanford reading center, 16 infants were classified as having TW-ROP based on telemedicine retinal image interpretation alone. Bedside BIO confirmed TW-ROP in 15 of the 16 infants. All 15 infants were treated with laser photocoagulation, and none of these infants progressed to macular fold, retrolental mass, retinal detachment, or severe vision loss (visual acuity worse than 20/200). The one infant with a false positive finding had ETROP type 2. This infant was followed up with serial examinations until his ROP spontaneously regressed. All 495 patients who did not have TW-ROP on image analysis were confirmed to have no TW-ROP during clinical examination and had no adverse outcomes reported.
Infants with TW-ROP had significantly lower birth weights (P < .001) and lower estimated gestational ages (P < .001) than infants without TW-ROP (Table 1 , page 112). The TW-ROP cohort had a higher proportion of male infants (66.7% vs 54.9%), but this difference was not statistically significant (P = .14, Fisher's exact test). There was also a greater percentage of multiples (twins and triplets) in the TW-ROP cohort (26.7% vs 15.3%), but this was not statistically significant (P = .27, Fisher's exact test). All infants with TW-ROP met WHO criteria for extremely low birth weight (less than 1,000 g; Table 2 , page 113).
Diagnostic Measures for Telemedicine
RetCam II image interpretation yielded one false positive and no false negatives ( Table 3 ). The sensitivity and NPV were 100%. The specificity was 99.8%, and the PPV was 93.8%.
DISCUSSION
The 5-year analysis of the SUNDROP telemedicine initiative exhibits excellent measures of diagnostic accuracy for the detection of TW-ROP with a sensitivity of 100%, specificity of 99.8%, PPV of 93.8%, and NPV of 100% using wide-angle retinal photography interpreted remotely and compared to the gold standard bedside BIO examination findings in outpatient clinic. Infants born at the six nurseries were screened solely with telemedicine as inpatients at a frequency determined by published recommendations until they met termination criteria or required treatment. 18 During the 5-year evaluation period, a single specialist screened 511 premature infants and no case of TW-ROP went undetected, as confirmed by bedside BIO of every infant discharged. 18 The SUNDROP initiative is a community-based ROP screening program led by Stanford University and represents the realworld implementation of telemedicine as a complementary tool for ROP screening.
In the United States, one in every nine infants born in 2012 was premature. 37 Although bedside BIO examination by an ophthalmologist is ideal, the limited ROP workforce is unable to keep up with the growing demand for care. Remote retinal photography may complement the work of ophthalmologists treating ROP by focusing their resources on infants with potentially vision-threatening disease. Previous studies have found many advantages to telemedicine for ROP screening. Remote image interpretation is faster, 38 is more cost-effective ($3,193 vs $5,617 for BIO for every quality-adjusted life year), 21 is less stressful to infants, 39 reduces the risks and costs of transporting premature infants, provides objective documentation of retinal findings, and provides records for training purposes. Telemedicine is currently being used for diabetic retinopathy care and has reduced the cost to patients and providers, increased access and availability for patients, and yielded no clinically significant sacrifices in the quality of care. 40 Telemedicine for ROP screening has been evaluated by multiple studies in the last two decades using various cameras, image takers, readers, reading centers, and distances between the patient and physician. Early trials reported mediocre sensitivities and specificities. 41 However, these studies used outdated camera and lens models, had readers of different training levels, and focused on the ability to distinguish between specific stages of ROP. [42] [43] [44] Ultimately, the purpose of screening is to detect disease that will alter the clinical course of the patient, which in the case of ROP is TW-ROP. In 2003, Ells et al embraced the tenets of an effective screening program and tested the utility of telemedicine for the detection of treatment-modifying disease. They reported a sensitivity of 100% and specificity of 96%. 22 All studies since then have reported similar diagnostic measures for detection of treatment-modifying disease when compared with simultaneous BIO. [22] [23] [24] [25] 27 In light of the growing body of evidence supporting the use of telemedicine for ROP screening, the AAO commissioned an ophthalmic technology assessment report in 2012 to review the published literature pertaining to the use of wide-angle digital photography for ROP screening. 45 The authors reviewed 82 studies, of which 10 met inclusion criteria and were rated as level 1 evidence (independent masked comparison to simultaneous comparison with BIO) [22] [23] [24] [25] 27 or level 3 evidence (BIO later in the infants course or only infants with ROP). 32, 43, 45, 46 The report found that telemedicine has high diagnostic accuracy for the detection of clinically significant ROP and that the sensitivity for detection of TW-ROP (ETROP type 1 or worse) across all studies was 100%. Taken together, these studies reported the diagnostic accuracy for the detection of TW-ROP with the following estimates (ranges): specificity 98% (93-100), PPV 85% (55-98), and NPV 100% (96-100). [22] [23] [24] [25] 27, 32, 43, 45, 46 The 5-year study results from the SUNDROP initiative are consistent with these estimates.
The incidence of TW-ROP in this study (15 of 496, 3.0%) is lower than that reported in other studies and national surveys (4% to 12%). 2, 4 At initial glance, it may seem that the SUNDROP population is not as sick as other groups. Closer examination of the cohort, however, demonstrates that this is not the case. The SUNDROP initiative serves a socioeconomically and ethnically diverse population stemming from six different NICUs including private, community, and county hospitals. By and large, this is a sick neonatal population with a mean birth weight and gestational age of the TW-ROP cohort similar to that reported in ETROP and other TW-ROP studies. 4, 11, 46 Among all infants enrolled in SUNDROP, 24% met WHO extremely low birth weight criteria (< 1,000 g). Thus, the apparent low incidence is likely a result of overreferral for screening. In our study, attending pediatricians and neonatologists are able to refer any infant they deem high risk for screening in accordance with the third AAP/AAO criteria. An unstable clinical course is a subjective criterion and more often than not, sick neonates are screened because the equipment is easily accessible and physicians would rather err on the side of caution. The indication for screening is not recorded in the SUNDROP database, and the screening specialist does not decline screening for any infant referred by the pediatrics team. Therefore, the seemingly low incidence in this population is likely secondary to a watering down of the denominator (total screening population) rather than an indication that the population screened is less sick than others have reported.
There are limitations that must be considered when interpreting the results of this study. The SUN-DROP initiative aims to detect disease that modifies treatment and thus only reports TW-ROP. Studies have demonstrated that although there is good agreement between retina specialists about TW-ROP on telemedicine images, agreement is not perfect. 47 Further, a single specialist performed all image interpretation, bedside BIO exams, and treatment, which may introduce bias into the study results.
The barriers to implementation and replication of programs such as the SUNDROP initiative should not be underestimated. The referral center or the nurseries must front capital to purchase a RetCam. The transition from a physician screening at the bedside to a nurse with a camera can be difficult for both health care staff and parents. Our team was able to develop strong community ties and explain the long-term benefits of telemedicine screening for ROP, but this required a trusting and amicable relationship with the hospital administration. The initiative required development of secure, encrypted, HIPAA-compliant electronic transmission systems that are able to reliably and promptly deliver retinal images. A key aspect of remote screening programs is communicating with the multidisciplinary team and clearly delineating the roles and responsibilities of every nurse, pediatrician, administrator, and ophthalmologist. These contracts varied by nursery and required regular meetings to ensure that every high-risk infant was screened and monitored in the pediatric ophthalmology clinic. Finally, for parents and health care staff to feel comfortable with this initiative, the protocol director needed to be available around the clock, interpreting multiple images every day without exception, and willing to travel to the bedside regardless of distance should any infant have a TW-ROP diagnosis on retinal photography.
In our experience, NICU nurses are ideal photographers. They are diligent, detail-oriented, and enthusiastic about being more involved in patient care. The majority of nurses felt comfortable taking images after one or two training sessions. There were occasional instances in which nurses were asked to re-image the retina because the images were not adequate for evaluation; however, most screenings were completed in one session with a median of 12.2 images per examination (goal of six images per eye). Overall, the nursing and health care staff at each nursery worked hard to ensure timely communication of information and cooperate with physician availability for bedside BIO examinations.
The SUNDROP initiative was able to successfully implement two new NICU nurseries since the last published update. The initial high-capital investment in the RetCam II purchase was accepted by new hospitals in light of the published SUNDROP results, [29] [30] [31] [32] [33] favorable local reputation of the SUNDROP staff, cost-effectiveness of ROP screening with telemedicine, and the ability to maintain NICU certification. In order to remain accredited, NICU nurseries must offer access to an ophthalmologist trained to screen for ROP, and the two new nurseries were able to meet this mandatory criterion because of their enrollment in the SUNDROP initiative.
Despite some limitations and challenges, the SUNDROP study was successful in meeting its initial goal of delivering quaternary care to all enrolled infants and reducing the burden of visual impairment and blindness in the greater Bay Area. This study's strength is that it represents the true clinical application of remote wide-angle image analysis in screening for ROP without the safety net of simultaneous bedside ophthalmic examination. Confirmation of the practical application of telemedicine in different regions is needed to better understand how this model will need to be adjusted in different practice environments. We now have 5 years of data supporting the use of telemedicine to complement the over-burdened ROP workforce. Telemedicine, as implemented in the SUNDROP initiative, assists the ROP workforce in identifying high-risk infants with vision-threatening disease and ensuring all premature infants have access to quaternary nursery level care, regardless of their birthplace.
